Akihiro Hirakawa

34PUBLICATIONS
169CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 08, 2026
Efficacy and Safety of Alectinib in Pediatric and Adult Patients with ALK-Altered Advanced Solid Tumors: a phase II TACKLE Trial (NCCH1712/MK003).

|Oct 07, 2026
Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer: A Copula-Based Secondary Analysis.

|Oct 05, 2026
BOIN12-PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression-Free Survival Endpoint.

|Aug 28, 2026
Efficacy of Vibegron in Overactive Bladder: A Bayesian Cross-Trial Synthesis of Benefit Probabilities and Decision Thresholds.

|Jul 26, 2026
Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial.

|Jul 22, 2026
Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

Pageof 6

Frequent Collaborators

11 joint publications

Hiroyuki Sato

6 joint publications

Soichiro Yoshida

6 joint publications

Ryoichi Hanazawa

5 joint publications

Hajime Tanaka